Avid Bioservices Inc (CDMO)

[Carboat]

Probably the biggest change in the landscape since we started enrollment is the approval of checkpoint inhibitors in this space, and we probably have patients that have received checkpoint therapy, and if there's an imbalance between the 2 arms of the study the subgroup analysis should account for that.

gee imagine that cancer patients are getting better care earlier and the soc is working better with these added therapies ....."That's not fair we want to get approved on the old numbers. Can we just get a bla no wait actually we changed our minds. Forget all that money we spent on the Sunrise, the years invested and the pain we inflicted on shareholders. Let's just forget all this chemo stuff (even though bavi works great here). We will just restart with IO - our shareholders won't mind no restructuring of the bavi chemo team, a reverse split, and more atm sales/dilution. " Yes this is a good plan.